Korean J Health Promot.  2023 Jun;23(2):55-64. 10.15384/kjhp.2023.23.2.55.

Associated Factors with Changes of Metabolic Abnormalities among General Population in COVID-19 Pandemic

• Kwon E
• Nah EH
• Kim S
• Cho S
• Park H

• KMID: 2544122
• DOI: http://doi.org/10.15384/kjhp.2023.23.2.55

Abstract

Background
The coronavirus disease-2019 (COVID-19) pandemic has led to restrictions on daily living including social distancing. These restrictions had an impact on the individual's healthy lifestyle and health status. We investigated the associated factors with changes of metabolic abnormalities among general population in COVID-19.
Methods
The participants were 43,639 people who received health check-ups twice in 2019 and 2021 during COVID-19 pandemic, at 16 health promotion centers. Metabolic abnormalities were identified according to the third report of the cholesterol education program criteria. Multiple logistic regression analysis was performed to confirm the factors related to changes of metabolic abnormalities during COVID-19.
Results
Metabolic syndrome and metabolic abnormalities increased overall during the COVID-19 pandemic. This increase was mostly appeared in males. The occurrence of metabolic syndrome during COVID-19 was associated with 50s and older age (odds ratio [OR], 1.130; 95% confidence interval [CI], 1.019-1.254), attempt to quit smoking (OR, 1.467; 95% CI, 1.171-1.839), start smoking (OR, 1.251; 95% CI, 1.110-1.412), decrease in aerobic exercise (OR, 1.328; 95% CI, 1.162-1.517), and increase in strength exercise (OR, 0.704; 95% CI, 0.592-0.838).
Conclusions
The metabolic syndrome is closely related to smoking experience and lack of exercise during COVID-19.

Keyword

COVID-19; Metabolic syndrome; Lifestyle; Social distancing

Reference

1. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. Geneva: World Health Organization; 2020 [cited Oct 26, 2022]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.

2. Ministry of Health and Welfare. Press releases: implement strong social distancing, the government will take the lead. The first half tobacco market trends in 2019 [Internet]. Sejong: Ministry of Health and Welfare; 2020 [cited Oct 26, 2022]. Available from: http://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&CONT_SEQ=353673.

3. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020; 395(10227):912–20.

4. Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr. 2020; 33(2):e100213.

5. Yılmaz C, Gökmen V. Neuroactive compounds in foods: occurrence, mechanism and potential health effects. Food Res Int. 2020; 128:108744.

6. Ammar A, Brach M, Trabelsi K, Chtourou H, Boukhris O, Masmoudi L, et al. Effects of COVID-19 home confinement on eating behaviour and physical activity: results of the ECLB-COVID 19 international online survey. Nutrients. 2020; 12(6):1583.

7. Pellegrini M, Ponzo V, Rosato R, Scumaci E, Goitre I, Benso A, et al. Changes in weight and nutritional habits in adults with obesity during the "lockdown" period caused by the COVID-19 virus emergency. Nutrients. 2020; 12(7):2016.

8. Mathew AR, Hogarth L, Leventhal AM, Cook JW, Hitsman B. Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model. Addiction. 2017; 112(3):401–12.

9. McHugh RK, Weiss RD. Alcohol use disorder and depressive disorders. Alcohol Res. 2019; 40(1):arcr.v40.1.01.

10. Guignard R, Andler R, Quatremère G, Pasquereau A, du Roscoät E, Arwidson P, et al. Changes in smoking and alcohol consumption during COVID-19-related lockdown: a cross-sectional study in France. Eur J Public Health. 2021; 31(5):1076–83.

11. Yoon MS, Jeong HS, Bae BY, Hong NY, Yim HW. Changes in daily physical activities by income level according to the prevalence of hypertension and diabetes during the COVID-19 pandemic: the 2020 community health survey. Korean J Health Educ Promot. 2022; 39(2):15–25.

12. Korean Society for the Study of Obesity. Survey on the current state of weight management and obesity awareness in COVID-19 pandemic [Internet]. Seoul: Korean Society for the Study of Obesity; 2021 [cited Oct 31, 2022]. Available from: http://general.kosso.or.kr/html/?pmode=BBBS0001300004&smode=view&seq=1372.

13. Korea Disease Control and Prevention Agency. Changes in health behaviors and chronic diseases after the COVID-19 pandemic [Internet]. Sejong: Korea Disease Control and Prevention Agency; 2021 [cited Oct 31, 2022]. Available from: https://www.korea.kr/archive/expDocView.do?docId=39785.

14. Sohn M, Koo BK, Yoon HI, Song KH, Kim ES, Kim HB, et al. Impact of COVID-19 and associated preventive measures on cardiometabolic risk factors in South Korea. J Obes Metab Syndr. 2021; 30(3):248–60.

15. Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021; 37(2):e3377.

16. Lim S, Shin SM, Nam GE, Jung CH, Koo BK. Proper management of people with obesity during the COVID-19 pandemic. J Obes Metab Syndr. 2020; 29(2):84–98.

17. Jeon WH, Seon JY, Park SY, Oh IH. Association of metabolic syndrome with COVID-19 in the Republic of Korea. Diabetes Metab J. 2022; 46(3):427–38.

18. Rhee SY. Diabetes, obesity, and COVID-19. J Korean Diabetes. 2021; 22(3):174–8.

19. Cho DH, Choi J, Gwon JG. Metabolic syndrome and the risk of COVID-19 infection: a nationwide population-based case-control study. Nutr Metab Cardiovasc Dis. 2021; 31(9):2596–604.

20. Jin SH, Kim KY. The association between changes in physical activity and its related factors during the COVID-19 pandemic-based on the data from 2020 community health survey in Daegu. J Health Info Stat. 2021; 46(4):393–401.

21. Kwon JY, Song SW, Kim HN, Kang SG. Changes in body mass index and prevalence of metabolic syndrome during COVID-19 lockdown period. Korean J Fam Pract. 2021; 11(4):304–11.

22. Expert Panel on Detection. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285(19):2486–97.

23. Yoon YS, Oh SW. Optimal waist circumference cutoff values for the diagnosis of abdominal obesity in Korean adults. Endocrinol Metab (Seoul). 2014; 29(4):418–26.

24. Korea Association of Health Promotion. 2017-2018 Korea Association of Health Promotion Health statistical yearbook [dissertation]. Seoul: Korea Association of Health Promotion; 2018-2019. Korean.

25. Korea Rural Economic Institute. The consumer behavior survey for food 2020 [Internet]. Naju: Korea Rural Economic Institute; 2020 [cited Nov 3, 2022]. Available from: https://www.krei.re.kr/krei/researchReportView.do?key=67&biblioId=530218&pageType=010101.

26. Martinez-Ferran M, de la Guía-Galipienso F, Sanchis-Gomar F, Pareja-Galeano H. Metabolic impacts of confinement during the COVID-19 pandemic due to modified diet and physical activity habits. Nutrients. 2020; 12(6):1549.

27. Cena H, Fonte ML, Turconi G. Relationship between smoking and metabolic syndrome. Nutr Rev. 2011; 69(12):745–53.

28. Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: a meta-analysis. Nicotine Tob Res. 2020; 22(9):1653–6.

29. Zvolensky MJ, Garey L, Rogers AH, Schmidt NB, Vujanovic AA, Storch EA, et al. Psychological, addictive, and health behavior implications of the COVID-19 pandemic. Behav Res Ther. 2020; 134:103715.